SEC Form 4 Reporting Owner · CIK 0001792726

James Basta

GC at Intellia Therapeutics Inc · GC at Kura Oncology Inc

Bought (12 mo) —
Sold (12 mo) −$112K
Form 4 Filings 11
Companies 2
Filing Activity 2026-03-03 first filed 2021-01-28

Trading record

Open-market buys — 0 filings
Open-market sales −$500K 8 filings
Sales under a 10b5-1 plan 0% 0 of 8 sale filings · 2 undisclosed

Companies

Open-market shares bought and sold at each company, and the holding after the latest filing
CompanyRoleFilingsBoughtSoldNetHolding after latest filing
NTLAIntellia Therapeutics Insider tradingGC10—29,582−29,582158,005 2026-03-03
KURAKura Oncology Insider tradingGC1————

Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.

Insider Trading History

Company Type Value Filed View filing
NTLA Intellia Therapeutics Inc Sell -$16,688 2026-03-03
NTLA Intellia Therapeutics Inc Sell -$95,756 2026-01-07
NTLA Intellia Therapeutics Inc Sell -$23,122 2025-03-04
NTLA Intellia Therapeutics Inc Sell -$86,161 2025-01-07
NTLA Intellia Therapeutics Inc Sell -$75,778 2024-03-05
NTLA Intellia Therapeutics Inc Sell -$112,095 2024-01-05
NTLA Intellia Therapeutics Inc Sell -$47,741 2023-03-03
NTLA Intellia Therapeutics Inc Sell -$42,345 2023-01-06
NTLA Intellia Therapeutics Inc Award — 2022-03-03
NTLA Intellia Therapeutics Inc Award — 2021-07-06
KURA Kura Oncology Inc Award — 2021-01-28